LJUBLJANA, Nov 16 (Reuters) - Slovenian generic drugs
producer Krka KRKG.LJ made group net profit of 110.1 million
euros ($129.72 million) in the first nine months of 2017 versus
80.3 million in the same period of 2016.
It said sales reached 928.3 million euros versus 852.4
million euros a year ago. The company said it expected 2017 net
profit to amount to 140 million euros.
Krka is Slovenia's largest listed company with a market
capitalisation of around 1.8 billion euros.
($1 = 0.8488 euros)
(Reporting by Marja Novak; Editing by Ivana Sekularac and Mark
Potter)
((ivana.sekularac@thomsonreuters.com; +381 11 30 44 930;
Reuters Messaging:
ivana.sekularac.thomsonreuters.com@reuters.net))
Keywords: KRKA RESULTS/